4//SEC Filing
Chilcott, III Thomas E. 4
Accession 0001209191-18-053322
CIK 0001411906other
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 5:29 PM ET
Size
8.4 KB
Accession
0001209191-18-053322
Insider Transaction Report
Form 4
Chilcott, III Thomas E.
Chief Financial Officer
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2018-10-01−75,000→ 0 totalExercise: $0.94Exp: 2027-01-18→ Common Stock (75,000 underlying) - Award
Stock Option (Right to Buy)
2018-10-01+75,000→ 75,000 totalExercise: $0.75Exp: 2027-01-18→ Common Stock (75,000 underlying)
Footnotes (2)
- [F1]The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") that became effective on October 1, 2018 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of each "Relevant Option" has been amended to reduce such exercise price to $0.75. There have been no other changes to the terms of the Relevant Options.
- [F2]The stock options vest and become exercisable in three equal installments. One-third of the options vested on the grant date of January 18, 2017; one-third of the options vested on January 18, 2018 and one-third of the options shall vest on January 18, 2019.
Documents
Issuer
Ampio Pharmaceuticals, Inc.
CIK 0001411906
Entity typeother
Related Parties
1- filerCIK 0001709573
Filing Metadata
- Form type
- 4
- Filed
- Oct 1, 8:00 PM ET
- Accepted
- Oct 2, 5:29 PM ET
- Size
- 8.4 KB